Alten R, Lorenz H-M, Mariette X, et al. Abatacept retention rates and prognostic factors of retention in patients with rheumatoid arthritis: 2-year results from the real-world ACTION study. EULAR 2017, FRI0245.
Betere aansluiting theorie en praktijk door patiëntenparticipatie
sep 2022 | Reumatoïde artritis, Sclerodermie